V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009450 | 220012067 | 1.77 | 94.8 | Curative (C) | 2016-03-31 | 2016-03-31 | CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA | Y | N | 220036675 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009451 | 220012067 | null | 106.8 | null | 2015-05-21 | 2015-05-22 | OCTREOTIDE | N | Y | 220036675 | OCTREOTIDE |
| 220009452 | 220012067 | null | 71 | Curative (C) | 2012-05-15 | 2015-01-13 | IDARUBICIN | 02 | null | 220036675 | IPILIMUMAB |
| 220009453 | 220012067 | 1.8 | 80 | Palliative (P) | 2015-12-29 | 2015-12-29 | Paclitaxel 7 day | N | N | 220036675 | VEMURAFENIB |
| 220009454 | 220012067 | null | null | null | 2013-12-06 | 2013-12-06 | ECarboX | N | null | 220036675 | IVE |
| 220009455 | 220012067 | null | 50.2 | Curative (C) | 2015-03-23 | 2015-04-07 | Carboplatin + Pemetrexed | N | N | 220036675 | TRIPLE INTRATHECAL |
| 220009456 | 220003842 | 0.01 | 64.5 | Palliative (P) | 2017-11-28 | 2017-11-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 220036692 | DABRAFENIB |
| 220009457 | 220003843 | 1.75 | 62 | Palliative (P) | 2012-12-31 | 2013-01-26 | CARBOPLATIN + RT | N | N | 220036693 | MITOXANTRONE |
| 220009458 | 220003844 | 1.56 | 44.8 | null | 2013-04-25 | 2013-05-01 | Fludarabine + Melphalan RIC Allo | N | N | 220036701 | FBC |
| 220009459 | 220003845 | 1.65 | 88.9 | Curative (C) | 2016-06-29 | 2016-06-29 | SPIRIT 2 TRIAL | N | N | 220036703 | CYCLOPHOSPHAMIDE |
| 220009460 | 220003846 | 1.69 | null | null | 2017-11-06 | 2017-11-08 | DOXORUBICIN | N | Y | 220036708 | BUSULPHAN |
| 220009461 | 220003847 | null | 0 | Curative (C) | 2013-09-23 | 2013-09-23 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 220036710 | CYTARABINE + FLUDARABINE |
| 220009462 | 220003847 | 1.78 | null | Palliative (P) | 2017-09-12 | 2017-09-12 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 220036710 | CAPECITABINE + CARBOPLATIN |
| 220009463 | 220016525 | null | null | null | 2014-02-28 | 2014-03-04 | ALL UKALL2011 Maintenance A2 | 0 | Y | 220036716 | FLUOROURACIL |
| 220009464 | 220019083 | 1.69 | 68 | Curative (C) | 2017-10-16 | 2017-10-17 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 220036717 | CYTARABINE + MITOXANTRONE |
| 220009465 | 220003848 | 1.71 | 108.5 | Palliative (P) | 2016-06-15 | 2016-06-18 | Dacarbazine | 2 | N | 220036722 | CISPLATIN + FLUOROURACIL |
| 220009466 | 220003849 | 1.7 | 56 | Curative (C) | 2014-07-29 | 2014-08-21 | Fludarabine + Melphalan RIC Allo | 02 | Y | 220036723 | FLUDARABINE + MELPHALAN |
| 220009467 | 220003850 | 1.93 | 70.8 | Disease modification (D) | null | 2018-04-10 | CISPLATIN + ETOPOSIDE | N | N | 220036725 | CYTARABINE INTRATHECAL |
| 220009468 | 220003851 | 1.68 | 4.3 | Curative (C) | 2017-11-16 | 2017-11-30 | Capecitabine | N | N | 220036727 | CLOFARABINE + CYTARABINE |
| 220009469 | 220003851 | 1.55 | 60.5 | Palliative (P) | 2016-04-07 | 2016-04-10 | Cisplatin + Paclitaxel | 02 | N | 220036727 | RUXOLITINIB |
| 220009470 | 220003852 | 1.8 | 55.6 | Disease modification (D) | 2017-11-26 | 2017-11-27 | UKALL14- Ph 1 Induction | N | N | 220036730 | DABRAFENIB + TRAMETINIB |
| 220009471 | 220012070 | 1.6 | 58.8 | Curative (C) | 2015-01-04 | 2015-01-09 | METHOTREXATE | 02 | N | 220036733 | ATG + BUSULFAN + FLUDARABINE |
| 220009472 | 220012070 | null | null | Curative (C) | 2013-11-03 | 2013-11-08 | Mitox + Tretinoin Spanish Course 3 | N | N | 220036733 | UKALL 2011 |
| 220009473 | 220019084 | 0 | null | null | 2014-04-06 | 2014-04-19 | Vemurafenib | N | N | 220036738 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220009474 | 220019084 | 1.69 | 0 | Curative (C) | 2014-12-18 | 2014-12-18 | ATG + Busulfan + Fludarabine | N | N | 220036738 | IDARUBICIN |
| 220009476 | 220012071 | null | null | Disease modification (D) | null | 2015-01-04 | Irinotecan + Modified De Gramont | null | null | 220036742 | ARSENIC TRIOXIDE |
| 220009477 | 220003854 | 1.75 | null | Curative (C) | 2015-10-02 | 2015-10-02 | Clofarabine + Cytarabine | 2 | N | 220036748 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009478 | 220003854 | 1.7 | 101.1 | Disease modification (D) | 2016-09-30 | 2016-10-16 | Mitoxantrone | N | N | 220036748 | DABRAFENIB + TRAMETINIB |
| 220009479 | 220003854 | null | null | Palliative (P) | 2013-07-26 | 2013-07-26 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | N | N | 220036748 | CISPLATIN + ETOPOSIDE |
| 220009481 | 220012073 | 1.56 | 0 | Palliative (P) | null | 2013-04-02 | Folfirinox | N | N | 220036755 | LI-1 TRIAL |
| 220009482 | 220012073 | 2 | 4 | Curative (C) | 2016-01-24 | 2016-01-25 | IDARUBICIN + MITOXANTRONE + Tretinoin | 02 | N | 220036755 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009483 | 220003856 | 1.8 | 101.6 | Palliative (P) | 2014-10-15 | 2014-10-26 | Fludarabine + Melphalan RIC Allo | N | N | 220036758 | PAZOPANIB |
| 220009484 | 220003857 | 1.73 | 65 | Curative (C) | null | 2017-09-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220036759 | FBC |
| 220009485 | 220003858 | 1.7 | 80 | null | 2018-01-01 | 2018-01-02 | ATG + Busulfan + Fludarabine | 02 | N | 220036760 | ATG + BUSULFAN + FLUDARABINE |
| 220009486 | 220003858 | null | 80 | Palliative (P) | 2014-10-20 | 2014-10-21 | Bortezomib + Cyclophos + Dex | N | N | 220036760 | DOXORUBICIN |
| 220009487 | 220003859 | 1.72 | null | Curative (C) | 2014-01-16 | 2014-01-16 | BOSUTINIB | N | N | 220036763 | DOXORUBICIN |
| 220009488 | 220003860 | 1.74 | 70 | Disease modification (D) | 2016-01-22 | 2016-02-05 | LANREOTIDE | N | Y | 220000626 | DABRAFENIB + TRAMETINIB |
| 220009489 | 220003861 | 0 | 66.2 | Radical (R) | 2013-07-24 | 2013-07-24 | OCTREOTIDE | N | N | 220000653 | IDARUBICIN |
| 220009490 | 220003862 | 1.8 | 66.6 | Curative (C) | 2017-05-03 | 2017-05-03 | ECarboX | Y | N | 220000773 | BOSUTINIB |
| 220009491 | 220003863 | null | null | null | 2017-02-11 | 2017-02-11 | GANETESPIB | N | N | 220001497 | DACARBAZINE |
| 220009492 | 220003864 | 0 | 64.8 | Curative (C) | 2013-08-16 | 2013-08-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 220001559 | ARSENIC TRIOXIDE + ATRA |
| 220009493 | 220003865 | 1.97 | 68.8 | Palliative (P) | 2016-10-04 | 2016-10-14 | Capecitabine | 02 | N | 220002427 | CAPECITABINE + IRINOTECAN |
| 220009494 | 220003865 | null | 40.8 | Curative (C) | 2015-09-30 | 2015-09-30 | LIPOSOMAL DOXORUBICIN | N | N | 220002427 | IDARUBICIN |
| 220009495 | 220003865 | null | 101 | Palliative (P) | 2017-12-24 | 2017-12-24 | Triple / Double Intrathecal Therapy | N | N | 220002427 | CISPLATIN + FLUOROURACIL |
| 220009496 | 220003866 | 1.78 | 105 | Curative (C) | 2016-09-09 | 2016-09-12 | Methotrexate intrathecal | 02 | N | 220003058 | PEG INTERFERON |
| 220009497 | 220003866 | 1.67 | 92.3 | Curative (C) | 2015-10-02 | 2015-10-02 | Cytarabine intrathecal | Y | N | 220003058 | UKALL2014 |
| 220009498 | 220003866 | 1.52 | 73.6 | Curative (C) | 2016-04-01 | 2016-04-01 | Carbo F | 02 | N | 220003058 | ARSENIC TRIOXIDE + TRETINOIN |
| 220009499 | 220003866 | null | 57.7 | Disease modification (D) | 2017-09-07 | 2017-09-09 | FLUDARABINE | Y | N | 220003058 | CYTARABINE INTRATHECAL |
| 220009500 | 220003867 | null | null | Palliative (P) | 2016-03-05 | 2016-03-16 | DOXORUBICIN | null | null | 220004682 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 220009502 | 220003869 | 1.7 | 108.5 | Curative (C) | 2017-01-27 | 2017-02-03 | CISPLATIN + ETOPOSIDE | 02 | N | 220006167 | ARSENIC TRIOXIDE + ATRA |